| CD38 |
P28907
|
CD38 molecule
|
Enzyme
|
2.3E-06 |
0.407 |
0.885 |
| CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
| CD40LG |
P29965
|
CD40 ligand
|
Signaling
|
0.72 |
0.414 |
0.846 |
| CD52 |
P31358
|
CD52 molecule
|
|
0.40 |
0.615 |
0.500 |
| CD79B |
P40259
|
CD79b molecule
|
Receptor
|
0.92 |
0.576 |
0.577 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CLEC4D |
Q8WXI8
|
C-type lectin domain family 4 member D
|
|
2.5E-06 |
0.587 |
0.538 |
| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
| CXADRP1 |
|
CXADR pseudogene 1
|
|
|
0.463 |
0.846 |
| CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
| CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
| CXCR5 |
P32302
|
C-X-C motif chemokine receptor 5
|
G-protein coupled receptor
|
0.73 |
0.524 |
0.769 |
| CYP2C9 |
P11712
|
cytochrome P450 family 2 subfamily C member 9
|
|
1.3E-10 |
0.506 |
0.885 |
| DNMT1 |
P26358
|
DNA methyltransferase 1
|
Epigenetic regulator
|
1.00 |
0.406 |
0.885 |
| ERCC2 |
P18074
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
Enzyme
|
7.1E-20 |
0.420 |
0.846 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| FASLG |
P48023
|
Fas ligand
|
Signaling
|
0.18 |
0.430 |
0.885 |
| FCGR3A |
P08637
|
Fc fragment of IgG receptor IIIa
|
Cell adhesion
|
3.7E-06 |
0.432 |
0.962 |
| FCGR3B |
O75015
|
Fc fragment of IgG receptor IIIb
|
Cell adhesion
|
3.0E-07 |
0.452 |
0.962 |
| FGF2 |
P09038
|
fibroblast growth factor 2
|
Signaling
|
1.8E-02 |
0.383 |
0.923 |